Table 1.

Comparison of response parameters in the presence of GAVSTA and control peptides

Peptide (n)	Baseline response characteristics (mean ± SEM)
	Initial slope	Amplitude	Area	Riset1/2	Decayt1/2	½ width
Control (16)	0.60  ± 0.02	1.29  ± 0.04	8.25  ± 0.37	1.95  ± 0.06	3.96  ± 0.14	5.91  ± 0.23
	(−mV · ms−1)	(−mV)	(mV · msec)	(msec)	(msec)	(msec)
GAVSTA (16)	0.59  ± 0.03	1.38  ± 0.05	8.94  ± 0.40	2.09  ± 0.05	3.86  ± 0.15	6.07  ± 0.20

Field EPSP parameters were assessed during the 1–2 min period immediately before the application of TBS. Peptides were infused for 50–90 min before baseline response characteristics were measured. Control: 2 mm ASG or 0.8 mm GRADSP, measured from 16 pathways. GAVSTA: 0.8 mm peptide in 16 pathways.